Global Peripheral Nerve Stimulators Market 2019-2023
SKU ID : TNV-14253029 | Publishing Date : 08-May-2019 | No. of pages : 131
Detailed TOC of Global Peripheral Nerve Stimulators Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Transcutaneous - Market size and forecast 2018-2023
Percutaneous - Market size and forecast 2018-2023
Implantable - Market size and forecast 2018-2023
Market opportunity by product
PART 07: MARKET SEGMENTATION BY STIMULATING FEATURE
Market segmentation by stimulating feature
Comparison by stimulating feature
PNS-TOF - Market size and forecast 2018-2023
PNS - Market size and forecast 2018-2023
Market opportunity by stimulating feature
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Technological advances
Wireless PNS
Industry developments
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Abbott
Avanos Corporate
B. Braun Melsungen AG
Boston Scientific Corp.
Medtronic
SPR Therapeutics Inc.
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Transcutaneous - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Transcutaneous - Year-over-year growth 2019-2023 (%)
Exhibit 21: Percutaneous - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Percutaneous - Year-over-year growth 2019-2023 (%)
Exhibit 23: Implantable - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Implantable - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Stimulating feature - Market share 2018-2023 (%)
Exhibit 27: Comparison by stimulating feature
Exhibit 28: PNS-TOF - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: PNS-TOF - Year-over-year growth 2019-2023 (%)
Exhibit 30: PNS - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: PNS - Year-over-year growth 2019-2023 (%)
Exhibit 32: Market opportunity by stimulating feature
Exhibit 33: Customer landscape
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: North America - Year-over-year growth 2019-2023 (%)
Exhibit 38: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 44: Key leading countries
Exhibit 45: Market opportunity
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Abbott - Vendor overview
Exhibit 53: Abbott - Business segments
Exhibit 54: Abbott - Organizational developments
Exhibit 55: Abbott - Geographic focus
Exhibit 56: Abbott - Segment focus
Exhibit 57: Abbott - Key offerings
Exhibit 58: Avanos Corporate - Vendor overview
Exhibit 59: Avanos Corporate - Business segments
Exhibit 60: Avanos Corporate - Organizational developments
Exhibit 61: Avanos Corporate - Geographic focus
Exhibit 62: Avanos Corporate - Segment focus
Exhibit 63: Avanos Corporate - Key offerings
Exhibit 64: B. Braun Melsungen AG - Vendor overview
Exhibit 65: B. Braun Melsungen AG - Business segments
Exhibit 66: B. Braun Melsungen AG - Organizational developments
Exhibit 67: B. Braun Melsungen AG - Geographic focus
Exhibit 68: B. Braun Melsungen AG - Segment focus
Exhibit 69: B. Braun Melsungen AG - Key offerings
Exhibit 70: Boston Scientific Corp. - Vendor overview
Exhibit 71: Boston Scientific Corp. - Business segments
Exhibit 72: Boston Scientific Corp. - Organizational developments
Exhibit 73: Boston Scientific Corp. - Geographic focus
Exhibit 74: Boston Scientific Corp. - Segment focus
Exhibit 75: Boston Scientific Corp. - Key offerings
Exhibit 76: Medtronic - Vendor overview
Exhibit 77: Medtronic - Business segments
Exhibit 78: Medtronic - Organizational developments
Exhibit 79: Medtronic - Geographic focus
Exhibit 80: Medtronic - Segment focus
Exhibit 81: Medtronic - Key offerings
Exhibit 82: SPR Therapeutics Inc. - Vendor overview
Exhibit 83: SPR Therapeutics Inc. - Business segments
Exhibit 84: SPR Therapeutics Inc. - Organizational developments
Exhibit 85: SPR Therapeutics Inc. - Key offerings
Exhibit 86: Validation techniques employed for market sizing
Exhibit 87: Definition of market positioning of vendors
Keyplayers in Global Peripheral Nerve Stimulators Market 2019-2023
AbbottAvanos Corporate
B. Braun Melsungen AG
Boston Scientific Corp.
Medtronic
SPR Therapeutics Inc.